logo
logo
Search For Features
/
StocksStocks
Intraday BoosterIntraday Booster
Sector BoosterSector Booster
Stock ScreenerStock Screener
Market PulseMarket Pulse
ScreenersScreeners
MoreMore

prime iconGo Prime
My PlansMy Plans
Privacy PolicyPrivacy Policy
ContactContact
Refer & EarnRefer & Earn
ScreenersScreeners
Main
Stock ScreenerStock Screener
Create ScreenerCreate Screener
Explore ScreenersExplore Screeners
Community ScreenersCommunity Screeners
Trading Screeners
CandleSticks ScreenerCandleSticks Screener
Top Gainers & LosersTop Gainers & Losers
Opening Range BreakoutOpening Range Breakout
Stock Screener AIStock Screener AI
Stock Quality ScorecardStock Quality Scorecard
Overvalued StocksOvervalued StocksNew
Undervalued StocksUndervalued StocksNew
Technical Screeners
NR4 StocksNR4 Stocks
NR7 StocksNR7 Stocks
Previous Day High BreakoutPrevious Day High Breakout
Previous Day Low BreakoutPrevious Day Low Breakout
Previous Day Open BreakoutPrevious Day Open Breakout
Bullish Crossover StocksBullish Crossover Stocks
Bearish Crossover StocksBearish Crossover Stocks
High Volume ShockerHigh Volume Shocker
VWAP Breakout StocksVWAP Breakout Stocks
Range High BreakoutRange High Breakout
Range Low BreakoutRange Low Breakout
MoreMore
Markets
Global Market TodayGlobal Market Today
Global IndicesGlobal Indices
Indian IndicesIndian Indices
NIfty TodayNIfty Today
Smart Money
FII DII DataFII DII DataNew
FII BuyingFII Buying
NSE Insider TradingNSE Insider Trading
SLB Stocks DataSLB Stocks Data
Derivatives
FnO MovementsFnO Movements
NSE F&O Lot SizeNSE F&O Lot Size
Ban ListBan List
Analysis & Calendars
Technical DashboardTechnical Dashboard
Sector BoosterSector Booster
Sector AnalysisSector AnalysisNew
Result CalendarResult Calendar
Economic CalendarEconomic Calendar
Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies

Small Cap323 EmployeesIPO 2016
Current Price
293.35
8.65 (3.04%)Updated
NSE :ADVENZYMES
BSE :540025
Sector :Chemicals
Today's Range
284.15
293.35
union icon
299.00
52 Week Range
52W Low259.00
52W High366.25
293.35
union icon
Downside13.26%
Upside24.85%

Price Chart

Compare with Peers

Historical Ratios

Track top 12 most important financial ratios

P/E Ratio: Price to Earnings - Most used valuation metric

Loading chart...

Analyzing Investment Quality

Processing 9 key metrics...

Key Metrics

Hover for details

Valuation

Market Cap
3,409.29 Cr
Market Cap
Total market value of company
P/E Ratio
22.39
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)
P/B Ratio
2.45
P/B Ratio
Price to Book Value. <3 may indicate undervaluation
EPS
13.59
EPS
Earnings Per Share. Higher and growing is positive

Profitability

ROE
4.81%
ROE
Return on Equity. >15% is good, >20% is excellent
ROCE
13.10%
ROCE
Return on Capital Employed. >15% is good
Net Margin
21.45%
Net Margin
Net profit as % of revenue. >10% is good
Operating Margin
-%
Operating Margin
Operating profit margin. >15% is good

Growth

EPS Growth (5Y)
0.25%
EPS Growth (5Y)
5-year EPS growth. >15% is strong
Revenue Growth (5Y)
7.48%
Revenue Growth (5Y)
5-year revenue growth. >10% is good
Qtr Sales Growth
20.30%
Qtr Sales Growth
Quarter-over-quarter sales growth
Qtr Profit Growth
16.90%
Qtr Profit Growth
Quarter-over-quarter profit growth

Financial Health

Debt/Equity
0.03
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellent
Book Value
128.09
Book Value
Net asset value per share
Dividend Yield
1.75%
Dividend Yield
Annual dividend as % of price. >2% is good
Promoter Holding
43.10%
Promoter Holding
Promoter stake. >50% shows confidence
Good
Average
Needs Attention

SWOT Analysis

Strengths

5 points
  • Robust 24.26% operating profit margin demonstrates strong operational efficiency.
  • Consistent quarterly profit growth of 16.90% indicates healthy business expansion.

Weaknesses

5 points
  • Promoter holding declined from 52.70% to 43.1%, signaling reduced confidence.
  • High P/E ratio of 25.30 suggests potential overvaluation compared to earnings.

Opportunities

4 points
  • Capitalize on increasing global demand for health and wellness biotechnology products.
  • Financial capacity (strong OPM, ROCE) to invest in R&D for new applications.

Threats

3 points
  • Intense competition from larger players with higher ROCE limits market share.
  • Stringent and evolving biotechnology regulations could impact product development and profitability.

Segment-wise Financial Analysis

Financial Results

Balance Sheet

StandaloneAnnualAll amounts in ₹ Crores • CA Schedule III Format

No Balance Sheet Data Available

Standalone annual data is not available for this symbol.
Try switching to Consolidated view.

Shareholding Pattern

Loading shareholding data...

Company Insider Trading Activity

Recent Insider Transactions

Insider NameTransaction DateFiling DateTotal SharesChangePriceAction
Vasant Rathi
24 Mar 202525 Mar 20253.71 Cr
1.50 L
₹291.05BUY
Atul Biyani
21 Mar 202525 Mar 20257,550
3,000
₹292.5BUY
Kishor Laxminarayan Rathi
20 Mar 202525 Mar 20254.06 L
11.00 L
-SELL
Kishor Laxminarayan Rathi HUF
20 Mar 202525 Mar 202511.00 L
11.00 L
-BUY
Vasant Rathi
26 Mar 202528 Mar 20253.71 Cr
25,000
₹282.54BUY
Payal Akshay Kulkarni
25 Mar 202528 Mar 20257,500
20,000
-SELL

Corporate Action

Company Announcements

Technical Analysis & Indicators

Standard pivot points - most widely used

Pivot Points (CLASSIC)

LevelPriceDistance% Change
R4329.88+₹36.53+12.45%
R3315.03+₹21.68+7.39%
R2307.02+₹13.67+4.66%
R1300.18+₹6.83+2.33%
PIVOT292.17-1.18-0.40%
CURRENT293.35--
S1255.63-₹37.72-12.86%
S2270.48-₹22.87-7.80%
S3277.32-₹16.03-5.47%
S4285.33-₹8.02-2.73%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: N/AP: N/ATC: N/A
R1
R2
R3
R4
indicator
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment

is trading CPR, indicating

● CPR Width

CPR is

● Opening Range

Day's range: ~

● Price Position

Trading Inside opening range

Delivery Volume Analysis & Trading Activity

Latest Volume
2.27L
(04 Mar 2026)
+44.1% vs avg
Delivery %
51.4%
(04 Mar 2026)
+1.0% vs avg
Avg Volume (20D)
1.58L
(04 Feb - 04 Mar)
20-day average
Avg Delivery %
50.4%
(04 Feb - 04 Mar)
Trend ↓
Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.

Peer Comparison & Industry Benchmarking

Quick Compare

Largest by Market Cap
Asian Paints Ltd
2.34L ₹ Cr
Best Profit Growth
Yasho Industries Ltd
248.00 %
Highest Dividend Yield
Asian Paints Ltd
1.03 %

Peer Comparison

Company Name
ASIANPAINT
Asian Paints Ltd
BALAMINES
Balaji Amines Ltd
CAMLINFINE
Camlin Fine Sciences Ltd
FCL
Fineotex Chemical Ltd
FOSECOIND
Foseco India Ltd
INDIGOPNTS
Indigo Paints Ltd
JUBLCPL
Jubilant Agri & Consumer Products Ltd
KIRIINDUS
Kiri Industries Ltd
LXCHEM
Laxmi Organic Industries Ltd
NEOGEN
Neogen Chemicals Ltd
ROSSARI
Rossari Biotech Ltd
RPEL
Raghav Productivity Enhancers Ltd
SHK
S H Kelkar & Company Ltd
TATVA
Tatva Chintan Pharma Chem Ltd
XPROINDIA
XPRO India Ltd
YASHO
Yasho Industries Ltd

About

ADVENZYMES

Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Limited (AET) is a global company specializing in the research, development, manufacturing, and marketing of enzymes and probiotics. Their operations span across numerous countries including India, Europe, the United States, and other regions in Asia. AET's business model centers on providing high-quality enzyme and probiotic solutions to a diverse range of industries.

AET's product portfolio caters to a wide spectrum of applications. A significant portion of their business involves supplying enzymes and probiotics for the food and beverage industry. This includes applications in fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, dairy and cheese processing, and oils and fats processing. They also offer specialized enzyme solutions for applications in biofuels and bio-catalysis.

Beyond the food industry, AET provides enzymes for non-food processing applications. These include enzymes used in the textile, leather, and pulp and paper industries. Furthermore, their products are utilized in the formulation of detergents and cleaning aids. In the healthcare sector, AET offers enzyme and probiotic-based nutritional supplements targeted at both human and animal health markets.

The company's history dates back to 1957, originally operating under the name Advanced Biochemicals Limited. In 2005, the company rebranded as Advanced Enzyme Technologies Limited, reflecting its focus on enzyme technology. Headquartered in Thane, India, AET has established a global presence, supplying its products and services to international markets. Their continued success hinges on ongoing research and development, allowing them to expand their product offerings and adapt to the evolving needs of their diverse customer base.

COMPANY FACTS - ADVENZYMES

Registered Address

5th Floor, 'A' wing, Sun Magnetica, LIC Service Road, Louiswadi, Thane (W)

Thane

MAHARASHTRA

IN

Company Details

Group: Materials

Sector: Materials

Industry: Chemicals

Exchange: NATIONAL STOCK EXCHANGE OF INDIA

Employees: 323

IPO Date: 01/08/2016

MANAGEMENT - ADVENZYMES

Mr. Vasant Rathi

Non-Executive Chairman of the Board

Mr. Beni Rauka

Chief Financial Officer

Mr. Dipak Roda

Senior Vice President - Business Development, Marketing

Mr. Mukund Kabra

Whole Time Director

Ms. Martina Doering

Managing Director and Head Of Business Development, Evoxx Technologies GmbH, Germany

Mr. Harshad Doshi

Chief Financial Officer and Chief Operating Officer of the US Subsidiaries

Dr. Michael Puls

Managing Director and Head Of Research and Development, Evoxx Technologies GmbH, Germany

Mr. Sanjay Basantani

Company Secretary and Head Legal

Ms. Rasika Rathi

Non-Executive Director

Dr. Sunny Sharma

Non-Executive Director

Mr. Nitin Deshmukh

Independent Director

Mr. Vinodkumar Jajoo

Independent Director

Investor Questions Answered

Advanced Enzyme Technologies Ltd (ADVENZYMES) Stock FAQs

Get answers to the most common questions about Advanced Enzyme Technologies Ltd stock price, fundamentals, financial metrics, and investment analysis

The current share price of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹293.35. Today, the stock has gained by ₹8.65 (3.04%), trading in a range of ₹284.15 to ₹299. The stock opened at ₹284.2 with a trading volume of 1,27,331 shares.
Advanced Enzyme Technologies Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹3,409.29 crores, P/E ratio of 22.39, ROE of 4.81%, and ROCE of 13.10%. The dividend yield stands at 1.75%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹366.25, while the 52-week low is ₹259. Currently trading at ₹293.35, the stock is 32.0% away from its 52-week low and 19.9% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Advanced Enzyme Technologies Ltd stock at ₹293.35 depends on multiple factors. The stock is currently trading with a P/E ratio of 22.39 and P/B ratio of N/A. Today's performance shows a gain of 3.04%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Advanced Enzyme Technologies Ltd offers a dividend yield of 1.75%, which means for every ₹100 invested at the current price of ₹293.35, you can expect to receive approximately ₹1.75 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Advanced Enzyme Technologies Ltd's key financial metrics include: P/E Ratio: 22.39, P/B Ratio: N/A, ROE: 4.81%, ROCE: 13.10%, Dividend Yield: 1.75%, EPS: ₹13.59, Book Value: ₹128.09, Debt-to-Equity: 0.03, and Current Ratio: N/A. The company's market cap stands at ₹3,409.29 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Advanced Enzyme Technologies Ltd stock opened at ₹284.2 and is currently trading at ₹293.35, showing a gain of ₹8.65 (3.04%). The intraday high is ₹299 and low is ₹284.15. The trading volume stands at 1,27,331 shares, indicating moderate market participation today.
Advanced Enzyme Technologies Ltd has a Price-to-Earnings (P/E) ratio of 22.39, which means investors are willing to pay ₹22.39 for every ₹1 of earnings. With an EPS of ₹13.59, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
Advanced Enzyme Technologies Ltd has a market capitalization of ₹3,409.29 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹293.35) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Advanced Enzyme Technologies Ltd has a book value of ₹128.09 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹293.35, which is 129.0% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Advanced Enzyme Technologies Ltd has a Return on Equity (ROE) of 4.81% and Return on Capital Employed (ROCE) of 13.10%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Advanced Enzyme Technologies Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Advanced Enzyme Technologies Ltd has a debt-to-equity ratio of 0.03, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Advanced Enzyme Technologies Ltd has an Earnings Per Share (EPS) of ₹13.59, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹293.35 and P/E ratio of 22.39, investors are paying 22.39 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Advanced Enzyme Technologies Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Advanced Enzyme Technologies Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Advanced Enzyme Technologies Ltd stock, consider: 1) Fundamental Analysis - Review P/E (22.39), ROE (4.81%), debt-to-equity (0.03), and growth rates. 2) Technical Analysis - Check 52-week range (₹259.00 - ₹366.25), moving averages, and chart patterns. 3) Valuation - Compare current price (₹293.35) with book value (₹128.09) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Advanced Enzyme Technologies Ltd share is ₹2.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹293.35 is 14568x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Advanced Enzyme Technologies Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹259.00 - ₹366.25). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.03 indicates leverage. 4) Liquidity Risk - Based on trading volume of 1,27,331 shares. 5) Valuation Risk - P/E of 22.39 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Advanced Enzyme Technologies Ltd operates in the industry with key metrics: P/E ratio of 22.39, ROE of 4.81%, market cap of ₹3,409.29 crores, and dividend yield of 1.75%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.03), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Advanced Enzyme Technologies Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹293.35, with a 52-week range of ₹259.00 to ₹366.25. Based on fundamentals like P/E (22.39), ROE (4.81%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Advanced Enzyme Technologies Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹293.35. 2) Fundamental Deterioration - Declining ROE (currently 4.81%), increasing debt (D/E: 0.03), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Advanced Enzyme Technologies Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 1.75%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.